Study guide
11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW)
Registered Cardiac Electrophysiology Specialist RCES
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pre-Procedural Assessment & Patient Preparation
1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping
2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations
2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination
3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety
3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure
4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring
4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs
5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab
6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals
6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction
7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology
8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias
8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria
9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition
9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics
10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)
11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints
11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation
12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing
12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)
13 Chapter 13: CIED Interrogation, Programming & Troubleshooting
13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing
14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies
14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism
15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management
15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover
11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW)
Key Takeaways Explain This Topic AI
Slow pathway ablation for AVNRT targets transitional nodal tissue located in the posteroinferior triangle of Koch between the coronary sinus ostium and the tricuspid valve annulus (zones P1/P2 and M1/M2), well away from the compact AV node and His bundle.
Target electrograms at the slow pathway site feature a small atrial deflection and large ventricular deflection (A:V ratio 1:3 to 1:5) accompanied by sharp, fragmented slow pathway potentials.
Accelerated junctional rhythm with intact 1:1 retrograde ventriculoatrial (V-A) conduction is the hallmark of effective slow pathway heating; immediate cessation of RF energy is mandatory if fast junctional rhythm (>120-140 bpm), V-A block, or PR prolongation occurs.
Procedural endpoints for AVNRT ablation require non-inducibility of tachycardia and elimination of dual AV nodal physiology under baseline and isoproterenol infusion, although a single echo beat without an AH jump is clinically acceptable.
Accessory pathway ablation requires mapping earliest ventricular activation during pre-excitation or earliest retrograde atrial activation during ventricular pacing/orthodromic AVRT; endpoints include immediate loss of pre-excitation (<3-5 s), persistent block during adenosine challenge, and concentric decremental AV nodal conduction.
Last updated: September 2026
11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW)
Catheter ablation of supraventricular tachycardias (SVT) represents one of the most successful and definitive curative interventions in interventional cardiac electrophysiology. The two most prevalent forms of paroxysmal SVT encountered in the clinical electrophysiology laboratory are atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT) mediated by accessory pathways in Wolff-Parkinson-White (WPW) syndrome or concealed bypass tracts.
Achieving high procedural success rates exceeding 95% to 98% while maintaining complication rates (such as complete heart block) below 0.5% requires deep comprehension of cardiac regional anatomy, fluoroscopic projections, intracardiac electrogram signatures, real-time physiological monitoring, and rigorous post-ablation endpoints.
- AVNRT Slow Pathway Ablation
- Pathophysiological Substrate & Dual AV Nodal Physiology
Typical AVNRT (slow-fast) requires dual atrioventricular nodal pathways exhibiting distinct electrophysiological properties:
Fast Pathway : Characterized by rapid conduction velocity and a relatively long effective refractory period ( E R P ERP ERP ). Anatomically, it courses anteriorly and superiorly along the tendon of Todaro near the apex of Koch's triangle, inserting into the compact AV node.
Slow Pathway : Characterized by slower conduction velocity and a relatively short E R P ERP ERP . Anatomically, it is composed of transitional atrial tissue and inferior nodal extensions running along the tricuspid valve annulus toward the coronary sinus ostium.
During sinus rhythm, impulses conduct preferentially down the fast pathway due to its rapid conduction velocity. A premature atrial complex (PAC) occurring at a critical coupling interval can find the fast pathway refractory, deflecting antegrade conduction down the slow pathway (manifesting as a sudden jump in the A H AH A H interval by ≥ 50 ms \ge 50\text{ ms} ≥ 50 ms for a 10 ms 10\text{ ms} 10 ms decrement in pacing coupling interval). By the time the impulse reaches the lower turnaround point in the compact node/His bundle, the fast pathway has recovered excitability, allowing retrograde conduction back to the atria and initiating sustained reentry. [Atrial Wavefront / PAC]
- |
- +------------------+------------------+
- | |
- [Fast Pathway] [Slow Pathway]
- (Long ERP, Fast Cond) (Short ERP, Slow Cond)
- | |
- Blocks Antegradely! Conducts Antegradely
- | (AH Jump >=50 ms)
- | |
- | [Lower Turnaround]
- | |
- +<======= Retrograde Flow <===========+
- The Triangle of Koch: Anatomical Boundaries & Zonal Mapping
The anatomical arena for slow pathway ablation is the Triangle of Koch , situated on the endocardial surface of the low right atrial interatrial septum. The boundaries of this vital triangle comprise:
Apex : The central fibrous body, where the compact atrioventricular node transitions into the penetrating bundle of His.
Anterior / Superior Border : The attachment (hinge line) of the septal leaflet of the tricuspid valve along the tricuspid annulus.
Posterior / Inferior Border : The Tendon of Todaro , a fibrous subendocardial cord running anteriorly from the Eustachian valve of the inferior vena cava (IVC) through the sinus septum to insert into the central fibrous body.
- Base : The ostium of the coronary sinus (CS os) and the Eustachian ridge. [Apex: Compact AV Node & His Bundle]
- / \
- / \
- / \
- [Anterior: Septal TV Annulus] / Zone A \ [Posterior: Tendon of Todaro]
- / \
- / Zone M1/M2 \
- / (Mid Septum) \
- / \
- / Zone P1/P2 \
- / (Inferior Isthmus) \
- +-------------------------+
- [Base: Coronary Sinus Ostium]
To minimize the risk of inadvertent damage to the compact AV node and penetrating His bundle, ablation is approached in a stepwise, inferior-to-superior fashion across defined anatomical zones:
Zone P (Posterior / Inferior) : Located at the base of the triangle, bounded between the anterior lip of the coronary sinus os and the tricuspid annulus (divided into P 1 P_1 P 1 deep within or near the CS os floor and P 2 P_2 P 2 along the anterior CS margin). This is the primary, safest target site for initial radiofrequency application.
Zone M (Mid-Septal) : Located midway between the CS os and the His bundle recording site ( M 1 M_1 M 1 and M 2 M_2 M 2 ). Ablation is advanced here only if applications in Zone P fail to eliminate slow pathway conduction.
Zone A (Anterior / Superior) : Located in close proximity to the apex of Koch's triangle where the compact AV node and His bundle reside. Ablation in Zone A is strictly avoided due to an unacceptable risk of permanent high-grade or complete atrioventricular block.
Electrogram Signatures at the Target Site
Precise positioning of the ablation catheter in Zone P requires continuous analysis of bipolar intracardiac electrograms recorded from the catheter tip (distal bipole 1 − 2 1-2 1 − 2 ):
Atrial-to-Ventricular Ratio ( A : V A:V A : V Ratio) : At the His bundle recording site at the apex of Koch's triangle, the A : V A:V A : V ratio is typically 1 : 1 1:1 1 : 1 to 1 : 2 1:2 1 : 2 with a sharp His deflection. As the ablation catheter is manipulated into the inferior triangle of Koch for slow pathway ablation, the local atrial electrogram becomes significantly smaller than the ventricular electrogram. The optimal slow pathway target displays a small atrial ( A A A ) to large ventricular ( V V V ) electrogram ratio between 1 : 3 1:3 1 : 3 and 1 : 5 1:5 1 : 5 (and up to 1 : 10 1:10 1 : 10 ). An A : V A:V A : V ratio > 1 : 1 >1:1 > 1 : 1 indicates the catheter is too superior or too high in the atrium, dangerously close to the compact AV node.
Slow Pathway Potentials : At successful target sites, a distinct, multicomponent, fragmented, or sharp high-frequency electrogram is recorded between the local atrial and ventricular signals. This "slow pathway potential" (often occurring 30 to 50 ms after the onset of low right atrial activation) reflects delayed activation of transitional nodal tissue and inferior extensions.
Real-Time Monitoring During Radiofrequency (RF) Delivery
Radiofrequency energy for slow pathway ablation is typically delivered using a 4 mm non-irrigated catheter (at 20 to 35 Watts, temperature limit 55°C to 60°C) or an irrigated catheter (at 25 to 35 Watts, flow rate 17 to 30 mL/min, power-controlled mode).
During energy delivery, the electrophysiology specialist must monitor specific electrographic hallmarks:
Junctional Rhythm (Accelerated Junctional Rhythm) : The development of an accelerated junctional rhythm (rate 60 to 110 bpm) during RF delivery is the clinical hallmark of successful slow pathway heating . It is produced by thermal automaticity in the nodal extensions. If no junctional rhythm appears within 15 to 20 seconds of RF delivery, the catheter is unlikely to be in the effective zone, and energy delivery should be aborted to reposition the catheter.
Mandatory 1:1 Retrograde V − A V-A V − A Conduction : It is paramount that every junctional beat conducts backward to the atria in a 1:1 fashion. This is confirmed by observing inverted P waves following each QRS on the surface ECG (leads II, III, aVF) and sharp retrograde atrial electrograms on the high right atrium (HRA) and coronary sinus recordings.
RF Red Flags & Immediate Cessation Criteria
Energy delivery must be terminated immediately (<1 second) upon the occurrence of any of the following warning signs to avoid permanent complete heart block:
Junctional Rhythm with V − A V-A V − A Block : Loss of retrograde ventriculoatrial conduction during junctional rhythm (a junctional QRS without a following retrograde atrial potential) indicates thermal injury spreading toward the compact AV node and is the most critical warning sign of impending complete heart block .
Fast Junctional Rhythm (>120 to 140 bpm) : Paroxysmal, irregular, or rapid junctional tachycardia indicates excessive heating or direct thermal irritation of the compact node itself.
Prolongation of the PR Interval or AH Interval : On sinus beats preceding or during energy delivery, any lengthening of the baseline PR or AH interval signifies fast pathway compromise.
Sudden Conduction Block or "Jump" : Any dropped P wave, sudden occurrence of second-degree AV block, or catheter dislodgement superiorly toward the His bundle.
Impedance Rise : An abrupt rise in impedance ( > 10 − 15 Ω >10-15\text{ }Ω > 10 − 15 Ω above baseline) indicates coagulum formation (charring) on the catheter tip, requiring immediate termination and catheter inspection.
Procedural Endpoints for AVNRT Ablation
Following lesion delivery, the EP specialist conducts comprehensive post-ablation programmed electrical stimulation under baseline conditions and during isoproterenol infusion (1 to 4 mcg/min, titrated to increase baseline sinus rate by ≥ 20 − 30 % \ge 20-30\% ≥ 20 − 30% ):
Complete Elimination of Slow Pathway Conduction : Demonstrated by the complete absence of an AH jump on single atrial extrastimulus testing ( S 1 − S 2 S_1-S_2 S 1 − S 2 ) and incremental atrial pacing.
Non-Inducibility of AVNRT : Inability to induce sustained or non-sustained AVNRT using single, double, or triple atrial extrastimuli across multiple drive cycle lengths (e.g., 600, 500, 400 ms) and rapid burst pacing down to the atrial effective refractory period ( A E R P AERP A ERP ).
Single Echo Beat (The Acceptable Endpoint) : In clinical practice, complete elimination of dual AV nodal physiology is not always achievable without risking compact nodal injury. The presence of an AH jump with at most a single AV nodal echo beat without tachycardia induction is considered a clinically successful and durable endpoint with low recurrence rates (<2-3%). Persistent multiple echo beats or inducible AVNRT requires further mapping and ablation.
- Accessory Pathway Ablation (WPW & Concealed AVRT)
- Anatomical Classification & Conduction Properties
Accessory atrioventricular pathways (Kent bundles) are abnormal muscular connections bridging atrial and ventricular myocardium across the fibrous annuli of the mitral or tricuspid valves.
Manifest Pathways (Wolff-Parkinson-White Syndrome) : Conduct antegradely from atrium to ventricle, producing ventricular pre-excitation (shortened PR interval <120 ms, slurred QRS upstroke or delta wave, and widened QRS complex). Most manifest pathways also conduct retrogradely.
Concealed Pathways : Conduct exclusively in the retrograde direction (ventricle to atrium). They exhibit a normal 12-lead ECG in sinus rhythm but serve as the retrograde limb in orthodromic atrioventricular reentrant tachycardia (AVRT).
Unlike the atrioventricular node, accessory pathways typically exhibit non-decremental conduction (all-or-none fixed conduction velocity independent of pacing rate) and shorter refractory periods, making them conduits for life-threatening rapid ventricular rates during atrial fibrillation.
12-Lead ECG Localization Algorithms
The spatial orientation of the accessory pathway along the atrioventricular annuli can be predicted non-invasively using 12-lead surface ECG algorithms (such as the Arruda and St. George's algorithms) during maximal pre-excitation:
Pathway Location Lead V 1 V_1 V 1 Delta Wave Inferior Leads (II, III, aVF) Delta Lead I & aVL Delta Key Electrographic Features
Left Lateral Strongly Positive ( R R R or R s Rs R s ) Positive Negative or Isoelectric Negative delta in aVL; steep transition across precordium
Left Posterior Strongly Positive ( R R R ) Negative or Biphasic Positive Precordial R / S > 1 R/S > 1 R / S > 1 in V 1 V_1 V 1 ; inferior Q-waves mimicking inferior MI
Left Anterolateral Positive Positive Negative (in I and aVL) Dominant R R R wave in V 1 V_1 V 1 ; upright inferior leads
Posteroseptal (Left/Right) Negative in V 1 V_1 V 1 (or QS in V 1 − V 2 V_1-V_2 V 1 − V 2 ) Deeply Negative (QS waves in II, III, aVF) Positive Deep negative delta waves across inferior leads; maximal septal pre-excitation
Right Free Wall Negative ( Q S QS QS or r S rS r S in V 1 V_1 V 1 ) Positive Positive LBBB-like morphology in V 1 V_1 V 1 ; late precordial transition ( V 3 − V 4 V_3-V_4 V 3 − V 4 )
Right Anteroseptal Negative ( Q S QS QS in V 1 V_1 V 1 ) Strongly Positive Positive LBBB-like; narrow delta; adjacent to His bundle (highest block risk)
Intracardiac Mapping Techniques
Definitive localization requires endocardial electroanatomic mapping:
Antegrade Pre-excitation Mapping (Manifest Pathways) : Mapping is performed during sinus rhythm or atrial pacing (atrial pacing close to the pathway maximizes pre-excitation). The catheter is moved along the annular circumference to identify the site of earliest local ventricular activation ( V V V ) relative to the onset of the surface delta wave . At the optimal target, local V V V precedes the delta wave by 10 to 30 ms.
Retrograde Mapping (Concealed or Manifest Pathways) : Mapping is performed during right ventricular pacing (apex or RVOT) or during orthodromic AVRT. The catheter is navigated along the atrial aspect of the annulus to identify the site of earliest retrograde atrial activation ( A A A ) relative to the onset of the surface retrograde P wave or ventricular electrogram.
Accessory Pathway Potential (Kent Potential) : At the precise insertion site, a discrete, sharp, high-frequency deflection (representing depolarization of the accessory pathway fibers) is recorded bridging the local atrial and ventricular signals. Fused, continuous electrical activity spanning from the local A A A wave into the local V V V wave with no isoelectric baseline indicates direct pathway contact. Normal Annular Site: (A) -------------- [Isoelectric Baseline] -------------- (V)
- |
- Successful Target Site: (A) ======= [Fused Kent Potential] ======= (V) |
- | | |
- +--- Precedes Delta Wave by 15-30 ms -----+ |
- |
- Surface ECG: [Delta Wave] === [Wide QRS Complex] ===+
- Left-Sided Accessory Pathways
Left-sided pathways account for 50% to 60% of all accessory connections (most frequently left lateral and left posterior):
Access Routes :
Transseptal Approach : The preferred, most common modern approach. A steerable sheath (e.g., Agilis) and ablation catheter are advanced across the fossa ovalis into the left atrium. The catheter rests on the atrial aspect of the mitral valve annulus, offering stable contact, excellent maneuverability, and lower systemic embolic risks.
Retrograde Transaortic Approach : The catheter is advanced from the femoral artery, across the aortic valve, into the left ventricle, and curved under the posterior or lateral leaflet of the mitral valve to contact the ventricular aspect of the mitral annulus. Requires careful anticoagulation and carries risks of aortic valve trauma, coronary ostial cannulation, and left ventricular ectopy.
Electrogram Targets : Simultaneous recording of coronary sinus (CS) electrograms guides localization. For example, earliest retrograde activation at CS 1-2 indicates a left lateral pathway, while earliest activation at CS 7-8 indicates a left posteroseptal pathway.
Right-Sided & Septal Pathways
Right-sided pathways (accounting for 20% to 30% of pathways) lie along the tricuspid annulus:
Right Free-Wall Pathways : Often associated with low-amplitude local electrograms and challenging catheter stability due to annular motion. Long guiding sheaths (e.g., Mullins or steerable sheaths) are required for mechanical backup.
Posteroseptal Pathways : Located in the vicinity of the coronary sinus ostium, the middle cardiac vein (MCV), and the posterior pyramidal space. Successful ablation may require RF delivery inside the proximal CS or MCV (using lower power, e.g., 20 to 25 Watts, with coronary angiography to rule out proximity to the posterior descending coronary artery).
Anteroseptal and Midseptal Pathways : Course near the compact AV node and His bundle. Intracardiac electrograms at these sites often display a prominent His potential alongside the pre-excited ventricular deflection. Ablation carries an exceptionally high risk of complete AV block. Cryoablation is frequently chosen over RF energy due to cryomapping (cooling to -30°C to confirm pathway loss without permanent tissue damage) before freezing to -80°C.
Ablation Endpoints for Accessory Pathways
Successful elimination of an accessory pathway requires meeting strict, verifiable electrophysiological endpoints:
Immediate Loss of Pre-excitation : During radiofrequency application in sinus rhythm, antegrade conduction across the pathway should cease within 3 to 5 seconds of RF onset, manifested by immediate disappearance of the delta wave, prolongation of the PR interval, and normalization of the QRS complex. If pre-excitation does not disappear within 5 to 10 seconds, RF delivery must be aborted and the catheter repositioned.
Concentric, Decremental Retrograde AV Nodal Conduction : During ventricular pacing post-ablation, retrograde atrial activation must convert from eccentric (earliest at the pathway site) to concentric (earliest at the His bundle and proximal CS) and demonstrate decremental properties (progressive lengthening of the V A VA V A interval in response to decremental pacing cycle lengths), proving that conduction is traveling exclusively through the normal AV node.
Adenosine Challenge : Intravenous administration of adenosine (6 to 12 mg bolus) produces transient atrioventricular nodal block. During sinus rhythm, adenosine should produce transient AV block without unmasking antegrade pre-excitation. During ventricular pacing, adenosine should produce transient ventriculoatrial (VA) block without retrograde pathway conduction, confirming the absence of dormant accessory pathway conduction.
Post-Ablation Observation Period : A mandatory 30-minute waiting period following the last RF delivery is observed. During this time, programmed stimulation and isoproterenol challenges are repeated to ensure that transient tissue edema has not created false-positive acute success.
Loading diagram... AVNRT Slow Pathway Ablation: Monitoring and Endpoint Algorithm
Procedural Endpoints Summary Table
Electrophysiological Parameter AVNRT Slow Pathway Ablation Manifest Accessory Pathway (WPW) Concealed Accessory Pathway (AVRT)
Target Anatomical Site Posteroinferior Triangle of Koch (Zones P1/P2, M1/M2) Mitral or Tricuspid Annulus at site of earliest local V V V Mitral or Tricuspid Annulus at site of earliest retrograde A A A
Target Local Electrogram A : V A:V A : V ratio 1:3 to 1:5; fragmented slow pathway potential Fused local A V AV A V ; local V V V precedes delta wave by 10-30 ms; Kent spike Local V A VA V A fusion; earliest retrograde A A A preceding surface P wave
Intra-application Hallmarks Accelerated junctional rhythm with intact 1:1 retrograde V − A V-A V − A Loss of delta wave and QRS normalization within 3 to 5 seconds Sudden separation of local V V V and A A A deflections; termination of AVRT
RF Termination Red Flags Junctional with V − A V-A V − A block, rate >120-140 bpm, PR lengthening Persistent pre-excitation >10s, impedance spike, catheter displacement Persistent pathway conduction >10s, VA block during AVRT, catheter slip
Definitive Procedural Endpoints Non-inducibility of AVNRT; AH jump eliminated or ≤ 1 \le 1 ≤ 1 echo beat Complete abolition of pre-excitation; concentric decremental AV nodal conduction Concentric decremental retrograde conduction; non-inducibility of AVRT
Post-Ablation Validation Isoproterenol challenge (1-4 mcg/min) and programmed atrial stimulation Adenosine bolus (transient AV block without delta wave); 30-min wait Adenosine during ventricular pacing (transient V A VA V A block); 30-min wait